Tavilermide |
MIM-D3; NMG938VJ6T (UNII code) |
Phase 3 Clinical |
Mimetogen Pharmaceuticals |
Keratoconjunctivitis Sicca; Dry Eye Syndromes |
Details
|
Lestaurtinib |
SPM-924; A-154475.0; KT-5555; SP-924; CEP-701 |
Phase 3 Clinical |
Kyowa Hakko Kirin Co Ltd |
Leukemia, Myeloid; Bone Marrow Neoplasms; Leukemia; Polycythemia Vera; Prostatic Neoplasms; Psoriasis; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Neuroblastoma; Primary Myelofibrosis; Leukemia, Myeloid, Acute; Thrombocythemia, Essential |
Details
|
SNA-125 |
CT-340; SNA-125 |
Phase 2 Clinical |
Sienna Biopharmaceuticals Inc, Creabilis Sa |
Pruritus; Psoriasis; Dermatitis, Atopic |
Details
|
Merestinib |
5OGS5K699E; LY-2801653 |
Phase 2 Clinical |
Eli Lilly And Company |
Biliary Tract Neoplasms; Skin Melanoma; Bone metastases; Solid tumours; Neoplasms; Pancreatic Neoplasms; Microsatellite instability-high cancer; Lymphoma, Mantle-Cell; Breast Neoplasms; Cholangiocarcinoma; Colorectal Neoplasms; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Gallbladder Neoplasms; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung |
Details
|
Milciclib maleate |
PHA-848125; TZLS-201; PHA-848125C; PHA-125; PHA-848125AC |
Phase 2 Clinical |
Tiziana Life Sciences Plc, Nerviano Medical Sciences Srl |
Solid tumours; Thymoma; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung |
Details
|
VC-004 |
VC004; VC-004; VC 004 |
Phase 2 Clinical |
Jiangsu Vcare Pharmatech Co Ltd |
Solid tumours; Pruritus; Cancer Pain; Dermatitis; Neoplasm Metastasis |
Details
|
XZP-5955 |
XZP-5955 |
Phase 2 Clinical |
Xuanzhu (Shijiazhuang) Biotechnology Co Ltd |
Solid tumours; Carcinoma, Non-Small-Cell Lung |
Details
|
BEN-2293 |
BEN-00002293; BEN-2293 |
Phase 2 Clinical |
Benevolentai Bio Ltd |
Dermatitis, Atopic |
Details
|
TQB-3558 |
TQB-3558; CT-3417 |
Phase 1 Clinical |
Beijing Centaurus Biopharma Co Ltd, Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd |
Solid tumours |
Details
|
ACD-856 |
ACD-856 |
Phase 1 Clinical |
Alzecure Pharma Ab |
Alzheimer Disease; Cognition Disorders |
Details
|
HG-030 |
HG-030 |
Phase 1 Clinical |
Hitgen Inc |
Solid tumours |
Details
|
AK-1830 |
AK-1830 |
Phase 1 Clinical |
Array Biopharma |
Inflammation |
Details
|
BR-01T |
BR01T; BR-01T |
Phase 1 Clinical |
Xiyuan Anjian Pharmaceutical (Shanghai) Co Ltd |
Low Back Pain |
Details
|
ND-003 (NewDEL Biotech) |
ND-003; ND003 |
Phase 1 Clinical |
Shenzhen NewDEL Biotech Co Ltd |
Solid tumours; Neoplasms; Idiopathic Pulmonary Fibrosis; Renal fibrosis; Pulmonary Fibrosis; Renal Insufficiency, Chronic; Dermatitis, Atopic |
Details
|
JND-5932 |
JND-5932; JND5932 |
Phase 1 Clinical |
Jinan University |
Neoplasms |
Details
|
PBI-200 |
PBI-200 |
Phase 1 Clinical |
Pyramid Biosciences |
Solid tumours; Desmoplastic Small Round Cell Tumor; Brain Neoplasms |
Details
|
TQB-3811 |
TQB-3811; CT-3872 |
Phase 1 Clinical |
Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd, Beijing Centaurus Biopharma Co Ltd |
Solid tumours |
Details
|
FCN-098 |
FCN-098; FCN098 |
Phase 1 Clinical |
Fochon Pharmaceuticals Ltd, Fochon Pharmaceuticals Ltd |
Solid tumours; Neoplasms |
Details
|
E-2511 |
E2511; E-2511 |
Phase 1 Clinical |
Eisai Inc |
|
Details
|
Beta-Nerve Growth Factor, Human (Aalborg University) |
|
Phase 1 Clinical |
Aalborg University Shakespeare Company |
Pain; Hyperalgesia |
Details
|
Recombinant human nerve growth factor (Beijing Tongren Hospital) |
|
Phase 1 Clinical |
Beijing Tongren Hospital, Cmu |
Optic Nerve Injuries |
Details
|
VMD-928 |
VMD-928 |
Phase 1 Clinical |
Vm Oncology Llc |
Head and Neck Neoplasms; Ovarian Neoplasms; Squamous Cell Carcinoma of Head and Neck; Pancreatic Neoplasms; Small Cell Lung Carcinoma; Urinary Bladder Neoplasms; Mesothelioma; Carcinoma, Adenoid Cystic; Sarcoma; Breast Neoplasms; Thymoma; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms |
Details
|
Tavilermide |
MIM-D3; NMG938VJ6T (UNII code) |
Phase 3 Clinical |
Mimetogen Pharmaceuticals |
Keratoconjunctivitis Sicca; Dry Eye Syndromes |
Details
|
Lestaurtinib |
SPM-924; A-154475.0; KT-5555; SP-924; CEP-701 |
Phase 3 Clinical |
Kyowa Hakko Kirin Co Ltd |
Leukemia, Myeloid; Bone Marrow Neoplasms; Leukemia; Polycythemia Vera; Prostatic Neoplasms; Psoriasis; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Neuroblastoma; Primary Myelofibrosis; Leukemia, Myeloid, Acute; Thrombocythemia, Essential |
Details
|
SNA-125 |
CT-340; SNA-125 |
Phase 2 Clinical |
Sienna Biopharmaceuticals Inc, Creabilis Sa |
Pruritus; Psoriasis; Dermatitis, Atopic |
Details
|
Merestinib |
5OGS5K699E; LY-2801653 |
Phase 2 Clinical |
Eli Lilly And Company |
Biliary Tract Neoplasms; Skin Melanoma; Bone metastases; Solid tumours; Neoplasms; Pancreatic Neoplasms; Microsatellite instability-high cancer; Lymphoma, Mantle-Cell; Breast Neoplasms; Cholangiocarcinoma; Colorectal Neoplasms; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Gallbladder Neoplasms; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung |
Details
|
Milciclib maleate |
PHA-848125; TZLS-201; PHA-848125C; PHA-125; PHA-848125AC |
Phase 2 Clinical |
Tiziana Life Sciences Plc, Nerviano Medical Sciences Srl |
Solid tumours; Thymoma; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung |
Details
|
VC-004 |
VC004; VC-004; VC 004 |
Phase 2 Clinical |
Jiangsu Vcare Pharmatech Co Ltd |
Solid tumours; Pruritus; Cancer Pain; Dermatitis; Neoplasm Metastasis |
Details
|
XZP-5955 |
XZP-5955 |
Phase 2 Clinical |
Xuanzhu (Shijiazhuang) Biotechnology Co Ltd |
Solid tumours; Carcinoma, Non-Small-Cell Lung |
Details
|
BEN-2293 |
BEN-00002293; BEN-2293 |
Phase 2 Clinical |
Benevolentai Bio Ltd |
Dermatitis, Atopic |
Details
|
TQB-3558 |
TQB-3558; CT-3417 |
Phase 1 Clinical |
Beijing Centaurus Biopharma Co Ltd, Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd |
Solid tumours |
Details
|
ACD-856 |
ACD-856 |
Phase 1 Clinical |
Alzecure Pharma Ab |
Alzheimer Disease; Cognition Disorders |
Details
|
HG-030 |
HG-030 |
Phase 1 Clinical |
Hitgen Inc |
Solid tumours |
Details
|
AK-1830 |
AK-1830 |
Phase 1 Clinical |
Array Biopharma |
Inflammation |
Details
|
BR-01T |
BR01T; BR-01T |
Phase 1 Clinical |
Xiyuan Anjian Pharmaceutical (Shanghai) Co Ltd |
Low Back Pain |
Details
|
ND-003 (NewDEL Biotech) |
ND-003; ND003 |
Phase 1 Clinical |
Shenzhen NewDEL Biotech Co Ltd |
Solid tumours; Neoplasms; Idiopathic Pulmonary Fibrosis; Renal fibrosis; Pulmonary Fibrosis; Renal Insufficiency, Chronic; Dermatitis, Atopic |
Details
|
JND-5932 |
JND-5932; JND5932 |
Phase 1 Clinical |
Jinan University |
Neoplasms |
Details
|
PBI-200 |
PBI-200 |
Phase 1 Clinical |
Pyramid Biosciences |
Solid tumours; Desmoplastic Small Round Cell Tumor; Brain Neoplasms |
Details
|
TQB-3811 |
TQB-3811; CT-3872 |
Phase 1 Clinical |
Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd, Beijing Centaurus Biopharma Co Ltd |
Solid tumours |
Details
|
FCN-098 |
FCN-098; FCN098 |
Phase 1 Clinical |
Fochon Pharmaceuticals Ltd, Fochon Pharmaceuticals Ltd |
Solid tumours; Neoplasms |
Details
|
E-2511 |
E2511; E-2511 |
Phase 1 Clinical |
Eisai Inc |
|
Details
|
Beta-Nerve Growth Factor, Human (Aalborg University) |
|
Phase 1 Clinical |
Aalborg University Shakespeare Company |
Pain; Hyperalgesia |
Details
|
Recombinant human nerve growth factor (Beijing Tongren Hospital) |
|
Phase 1 Clinical |
Beijing Tongren Hospital, Cmu |
Optic Nerve Injuries |
Details
|
VMD-928 |
VMD-928 |
Phase 1 Clinical |
Vm Oncology Llc |
Head and Neck Neoplasms; Ovarian Neoplasms; Squamous Cell Carcinoma of Head and Neck; Pancreatic Neoplasms; Small Cell Lung Carcinoma; Urinary Bladder Neoplasms; Mesothelioma; Carcinoma, Adenoid Cystic; Sarcoma; Breast Neoplasms; Thymoma; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms |
Details
|